Healthcare Regulatory Environment in Nigeria and Ghana, 2018
|発行||Frost & Sullivan||商品コード||760905|
|出版日||ページ情報||英文 55 Pages
|ナイジェリアおよびガーナにおける医療関連法規制：2018年 Healthcare Regulatory Environment in Nigeria and Ghana, 2018|
|出版日: 2018年12月13日||ページ情報: 英文 55 Pages||
Unlocking Investment Potential and Improving Healthcare Delivery and Access through Policy Advancement
The West African region has a handful of emerging economies within Sub-Saharan Africa in terms of overall development and growth. The region currently has a high number of people living in extreme poverty, particularly in Nigeria, as well as a high population density. Furthermore, there has been a growing trend of non-communicable diseases, such as cancer and diabetes, which pose an additional strain on the healthcare systems of the respective countries. Despite positive developments in healthcare over the past decade, the health sector currently faces a number of regulatory challenges. These have a knock-on effect on the rest of the economy, requiring smart prioritisation of available resources. While various health strategies have been enforced across different countries in the region, their levels of success have been somewhat marginal. A deeper understanding of the different regulations covering key sectors and their successes and/or failures is highlighted in this study. Significant investment in healthcare and its allied industries' for these two countries can be realised by unpacking the respective regulations in the sub-sectors of the healthcare market, assessing the history, development trends, future plans and future impact. Furthermore, the required areas of transformation can be realised using this research deliverable. Although some sub-sectors' regulations are more advanced than others, the regulatory aspects and impact cannot be separated. It is therefore necessary to understand the market as a whole, with cross-sector opportunities, particularly given the competition arriving from other African regions.
The study covers the following healthcare segments: public health, healthcare finance, pharmaceuticals, medical devices, eHealth.